Duncan Jodrell

12PUBLICATIONS
79CO-AUTHORS
Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Tumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Oct 31, 2025
Transcription factor switching drives subtype-specific pancreatic cancer.

Shalini V Rao, Lisa Young, Danya Cheeseman

|May 12, 2025
First-in-Human Study to Evaluate the Safety and Efficacy of Anti-GDF15 Antibody AZD8853 in Patients with Advanced/Metastatic Solid Tumors.

Benedito A Carneiro, Olumide B Gbolahan, Albiruni Abdul Abdul Razak

|May 24, 2024
Intratumoral antigen signaling traps CD8<sup>+</sup> T cells to confine exhaustion to the tumor site.

Munetomo Takahashi, Tsz Y So, Vitalina Chamberlain-Evans

|Feb 22, 2023
Clinical and biological markers predictive of treatment response associated with metastatic pancreatic adenocarcinoma.

Alimu Dayimu, Lorena Di Lisio, Shubha Anand

|Feb 25, 2022
Early Neutrophilia Marked by Aerobic Glycolysis Sustains Host Metabolism and Delays Cancer Cachexia.

Michele Petruzzelli, Miriam Ferrer, Martijn J Schuijs

Pageof 2